NVCN logo

Neovasc (NVCN) Stock

Profile

Full Name:

Neovasc Inc.

Sector:

Healthcare

Country:

Canada

IPO:

23 May 2001

Indexes:

Not included

Description:

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include Tiara for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada. As of April 11, 2023, Neovasc Inc. operates as a subsidiary of Shockwave Medical, Inc.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Mar 10, 2022

Recent annual earnings:

Mar 10, 2022
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Apr 29, 2022

Analyst ratings

Recent major analysts updates

25 Nov '20 Northland Securities
Outperform
25 Nov '20 Leerink Swann
Outperform
25 Nov '20 Ladenburg Thalmann
Buy
25 Nov '20 JMP Securities
Market Outperform
25 Nov '20 H.C. Wainwright
Buy
25 Nov '20 Canaccord Genuity
Buy
06 Nov '20 SVB Leerink
Outperform

Screeners with NVCN included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Similar stocks

FAQ

  • What is the primary business of Neovasc?
  • What is the ticker symbol for Neovasc?
  • Does Neovasc pay dividends?
  • What sector is Neovasc in?
  • What industry is Neovasc in?
  • What country is Neovasc based in?
  • When did Neovasc go public?
  • Is Neovasc in the S&P 500?
  • Is Neovasc in the NASDAQ 100?
  • Is Neovasc in the Dow Jones?
  • When was Neovasc's last earnings report?
  • When does Neovasc report earnings?
  • Should I buy Neovasc stock now?

What is the primary business of Neovasc?

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include Tiara for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada. As of April 11, 2023, Neovasc Inc. operates as a subsidiary of Shockwave Medical, Inc.

What is the ticker symbol for Neovasc?

The ticker symbol for Neovasc is NASDAQ:NVCN

Does Neovasc pay dividends?

No, Neovasc does not pay dividends

What sector is Neovasc in?

Neovasc is in the Healthcare sector

What industry is Neovasc in?

Neovasc is in the Medical Devices industry

What country is Neovasc based in?

Neovasc is headquartered in Canada

When did Neovasc go public?

Neovasc's initial public offering (IPO) was on 23 May 2001

Is Neovasc in the S&P 500?

No, Neovasc is not included in the S&P 500 index

Is Neovasc in the NASDAQ 100?

No, Neovasc is not included in the NASDAQ 100 index

Is Neovasc in the Dow Jones?

No, Neovasc is not included in the Dow Jones index

When was Neovasc's last earnings report?

Neovasc's most recent earnings report was on 10 March 2022

When does Neovasc report earnings?

The date for Neovasc's next earnings report has not been announced yet

Should I buy Neovasc stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions